Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Effect of semaglutide on liver measures and indices: pooled analysis from the STEP UP trials

Authors :

Eric Lawitz1; W. Timothy Garvey2; Christine Sofie Fuchs Jacobsen3; María Quiroga3; Lauren Wilson4; Philip N. Newsome5

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Download poster (.pdf)
Keywords
Obesity
Congress short oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)